Lipopolysaccharide (LPS) contributes to
asthma exacerbations and development of inhaled
corticosteroid insensitivity. Complete resistance to systemic
corticosteroids is rare, and most patients lie on a continuum of
steroid responsiveness. This study aimed to examine the sensitivity of combined
ovalbumin- (Ova) and LPS-induced functional and inflammatory responses to inhaled and systemic
corticosteroid in conscious guinea pigs to test the hypothesis that the route of administration affects sensitivity. Guinea pigs were sensitized to Ova and challenged with inhaled Ova alone or combined with LPS. Airway function was determined by measuring specific airway conductance via whole-body plethysmography.
Airway hyper-responsiveness to
histamine was determined before and 24 hours post-Ova challenge. Airway
inflammation and underlying mechanisms were determined from bronchoalveolar lavage cell counts and lung tissue
cytokines. Vehicle or
dexamethasone was administered by once-daily i.p. injection (5, 10, or 20 mg/kg) or twice-daily inhalation (4 or 20 mg/ml) for 6 days before Ova challenge or Ova with LPS. LPS exacerbated Ova-induced responses, elongating early asthmatic responses (EAR), prolonging
histamine bronchoconstriction, and further elevating airway
inflammation. Intraperitoneal
dexamethasone (20 mg/kg) significantly reduced the elongated EAR and airway
inflammation but not the increased bronchoconstriction to
histamine. In contrast, inhaled
dexamethasone (20 mg/ml), which inhibited responses to Ova alone, did not significantly reduce functional and inflammatory responses to combined Ova and LPS. Combined Ova and LPS-induced functional and inflammatory responses are insensitive to inhaled, but they are only partially sensitive to systemic,
dexamethasone. This finding suggests that the route of
corticosteroid administration may be important in determining
corticosteroid sensitivity of asthmatic responses.